LivaNova PLC
NASDAQ:LIVNMedical - Devices
+$0.76 today
- Market cap
- $5.21B
- Beta
- 0.88
- P/E (TTM)
- 40.5
- EPS (TTM)
- $1.96
Volume 1.32M
Average 0.79M
LIVN Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
LivaNova PLCNASDAQ: LIVN
Net Margin · Q3 FY2026 · quarter ended Sep 2026
Net margin widens to 8.7%
Net margin was 8.7% in Q3 FY2026, up 1.2 pp from a year earlier. On a trailing-twelve-month basis it was 13.0%, up 29.1 pp year over year. Over 3 fiscal years it narrowed by 9.0 pp.
Context
- Net margin widened in 2 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
What to watch
Whether net margin reaches the consensus estimate from 8 analysts of 15.7% for the fiscal year ending Dec 2026, up from -17.5% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 8.7%-19.1 pp QoQ
- Last fiscal yearDec 2025
- -17.5%-22.5 pp YoY
- LTMSep 2026
- 13.0%+29.1 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +1.2 pp | +5.8 pp | +4.5 pp |
| 1 year | -22.5 pp | +33.2 pp | +55.7 pp |
| 3 years | -9.0 pp | +34.4 pp | +43.5 pp |
| 5 years | +36.4 pp | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -17.5%
- Year-over-year change
- -22.5pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -17.5% | -22.5pp |
| FY2024 | 2024-12-31 | 5.0% | +3.5pp |
| FY2023 | 2023-12-31 | 1.5% | +10.0pp |
| FY2022 | 2022-12-31 | -8.4% | +4.7pp |
| FY2021 | 2021-12-31 | -13.1% | — |
Net Margin vs competitors
How LIVN compares with its peers on the latest reported figures
- LIVN's LTM Sep 2026 net margin of 13.0% is the 6th highest of the 10 companies compared; the peer median is 13.9%.
- Its year-over-year change of +29.1 pp is the 2nd highest of 10, against a peer median of +3.9 pp.
- Over three fiscal years its change of -9.0 pp compares with a peer median of +8.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 26.9% | -0.3 pp | +5.7 pp | |
| LTM Jun 2026 | 17.5% | +3.9 pp | +8.9 pp | |
| LTM Jun 2026 | 15.4% | -57.5 pp | -10.6 pp | |
| LTM Jun 2026 | 15.0% | +8.9 pp | +26.9 pp | |
| LTM Jul 2026 | 13.9% | +0.3 pp | +1.2 pp | |
| LTM Sep 2026 | 13.0% | +29.1 pp | -9.0 pp | |
| LTM Jun 2026 | 7.1% | -5.0 pp | -2.6 pp | |
| LTM Mar 2026 | -21.7% | +7.8 pp | +82.0 pp | |
| LTM Mar 2026 | -24.5% | +29.8 pp | +30.8 pp | |
| LTM Mar 2026 | -89.1% | +8.3 pp | +90.3 pp | |
MOBIMobia Medical, Inc. Common Stock | — | — | — | — |
| Peer median (excluding LIVN) | 13.9% | +3.9 pp | +8.9 pp | |
Competitors are the stored peer set for LIVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.04B | 1.02B | 1.15B | 1.25B | 1.39B |
| Cost of Revenue | 329.37M | 314.58M | 382.3M | 382.56M | 448.2M |
| Gross Profit | 705.99M | 707.23M | 771.25M | 870.87M | 939.9M |
| Gross Margin | 68.2% | 69.2% | 66.9% | 69.5% | 67.7% |
| Research & Development | 183.41M | 155.81M | 193.82M | 182.51M | 185.8M |
| Selling, General & Admin | 471.9M | 469.24M | 518.13M | 526.27M | 548.8M |
| Operating Expenses | 706.78M | 783.98M | 839.75M | 741.82M | 740.5M |
| Depreciation & Amortization | 67.99M | 57.8M | 60.86M | 51.14M | 42M |
| EBITDA | (6.33M) | 30.9M | 38.48M | 202.52M | (129.5M) |
| EBITDA Margin | -0.6% | 3.0% | 3.3% | 16.2% | -9.3% |
| Operating Income | (784K) | (76.75M) | (68.5M) | 129.05M | 199.4M |
| Operating Margin | -0.1% | -7.5% | -5.9% | 10.3% | 14.4% |
| Interest Income | 435K | 4.7M | 22.01M | 30.08M | 18.98M |
| Interest Expense | 50.15M | 48.25M | 58.85M | 63.07M | 49.29M |
| Other Income / Expenses | (123.84M) | 1.56M | (12.83M) | (40.74M) | (420.2M) |
| Income Before Tax | (124.62M) | (75.2M) | (81.33M) | 88.31M | (220.8M) |
| Pre-Tax Margin | -12.0% | -7.4% | -7.1% | 7.0% | -15.9% |
| Income Tax Expense | 11.2M | 11.05M | (98.88M) | 25.06M | 21.6M |
| Net Income | (135.82M) | (86.25M) | 17.55M | 63.23M | (242.5M) |
| Net Margin | -13.1% | -8.4% | 1.5% | 5.0% | -17.5% |
| EPS (Basic) | (2.68) | (1.61) | 0.33 | 1.17 | (4.45) |
| EPS (Diluted) | (2.68) | (1.61) | 0.32 | 1.16 | (4.45) |
| Weighted Avg Shares | 50.63M | 53.5M | 53.9M | 54.24M | 54.5M |
| Weighted Avg Shares (Diluted) | 50.63M | 53.5M | 54.21M | 54.57M | 54.5M |
LivaNova PLC
NASDAQ:LIVN
Intrinsic Alpha fair value
Locked
Current Price
$94.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.